Scientific integrity, fidelity and conflicts of interest in research

Current Opinion in Psychiatry

Volumn 17, Issue 5, 2004, Pages 381-385

  Warner, Teddy D ^a   Roberts, Laura Weiss ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; MEDICAL DOCUMENTATION; MEDICAL SCHOOL; PREVALENCE; PROFESSIONAL MISCONDUCT; RESEARCH; REVIEW; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DRUG INDUSTRY; EMPIRICAL RESEARCH; ETHICS COMMITTEES, RESEARCH; GREAT BRITAIN; HUMAN EXPERIMENTATION; HUMANS; INTERINSTITUTIONAL RELATIONS; ORGANIZATIONAL POLICY; PHYSICIANS; PUBLISHING; RESEARCH PERSONNEL; RESEARCH SUPPORT; UNITED STATES; UNIVERSITIES;

EID: 4344638481     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000139974.45189.96     Document Type: Review

References (56)

1. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Washington, D.C.: Government Printing Office; 1979.
2. Levine RJ. Ethics and regulation of clinical research. Baltimore: Urban & Schwartzenberg; 1986.
3. Brody B. The ethics of biomedical research: an international perspective. New York: Oxford University Press; 1998.
4. Katz D, Caplan AL, Merz JF. All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth 2003; 3:39-46.
5. Jansen LA, Sulmasy DP. Bioethics, conflicts of interest, and the limits of transparency. Hastings Cent Rep 2003; 33:40-43.
6. Healy D, Thase ME. Is academic psychiatry for sale? Br J Psychiatry 2003; 182:388-390.
7. Steinbrook R. Financial conflicts of interest and the NIH. N Engl J Med 2004; 350:327-330.
8. Institute of Medicine National Research Council of the National Academies. Integrity in Scientific Research. Washington D.C.: The National Academies Press; 2002.
9. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York: Oxford University Press; 2001.
10. Roberts LW, Dyer AR. Concise guide to ethics in mental health care. Washington D.C.: American Psychiatric Publishing Inc.; 2004.
11. Roberts LW. Ethical dimensions of psychiatric research: a constructive, criterion-based approach to protocol preparation - the research protocol ethics assessment tool (RePEAT). Biol Psychiatry 1999; 46:1106-1119.
12. Spece RG, Shimm DS, Buchanan AE, editors. Conflicts of interest in clinical practice and research. New York: Oxford University Press; 1996.
13. Holmes DR, Firth BG, James A, et al. Conflict of interest. Am Heart J 2004; 147:228-237.
14. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress I: Policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med 2003; 78:225-236.
15. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress II: Principles and recommendations for oversight of an institution's financial interests in human subjects research. Acad Med 2003; 78:237-245.
16. Roberts LW, Dyer AR. Ethical issues in clinical training. In: Concise guide to ethics in mental health care. Washington D.C.: American Psychiatric Publishing Inc.; 2004.
17. Roberts LW, Dyer AR. Caring for difficult patients. In: Concise guide to ethics in mental health care. Washington D.C.: American Psychiatric Publishing Inc.; 2004.
18. Warner TD, Gluck J. What do we really know about conflicts of interest in research in biomedical research? Psychopharmacology 2003; 45:44-55.
19. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003; 290:252-255.
20. Epstein RS, Simon RI. The exploitation index: an early warning indicator of boundary violations in psychotherapy. Bull Menninger Clinic 1990; 54:450-465.
21. American Medical Association Council on Ethical and Judicial Affairs. Code of medical ethics: Current opinions with annotations, 2002-2003 Edition. Chicago: American Medical Association; 2002.
22. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ 1995; 310:1660-1661.
23. National Institutes of Health. Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Studies. Bethesda, MD: National Institutes of Health; May 2004.
24. Blumenthal D. Academic-industrial relationships in the life sciences. N Engl J Med 2003; 349:2452-2458.
25. Blumenthal D, Campbell EG, Causino N, Louis KS. Participation of life science faculty in research relationships with industry: extent and effects. N Engl J Med 1996; 335:1734-1739.
26. Blumenthal D, Causino N, Campbell EG. Academic-industry research relationships in genetics: a field apart. Nat Genet 1997; 16:104-107.
27. Blumenthal D, Causino N, Campbell EG, Louis KS. Relationships between academic institutions and industry: an industry survey. N Engl J Med 1996; 334:368-373.
28. Schafer A. Biomedical conflicts of interest. A defense of the sequestration thesis: learning from the cases of Nancy Olivieri and David Healy. J Med Ethics 2004; 30:8-24.
29. Bodenheimer T. Uneasy alliance: Clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342:1539-1544.
30. Goldman CR, Cutler DL. Pharmaceutical industry support of psychiatric research and education: ethical issues and proposed remedies. In: Backlar P, Cutler DL, editors. Ethics in community mental health care: commonplace concerns. New York: Kluwer Academic/Plenum; 2002. pp. 209-233.
31. Henderson JA, Smith JJ. Financial conflict of interest in medical research: Overview and analysis of institutional controls. Food Drug Law J 2003; 58:251-267.
32. Tereskerz PM. Research accountability and financial conflicts of interest in industry-sponsored clinical research: A review. Account Res 2003; 10:137-158.
33. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289:454-465.
34. Krimsky S, Rothenberg LS, Stott P, Kyle G. Scientific journals and their authors' financial interests: a pilot study. Psychother Psychosom 1998; 67:194-201.
35. Boyd EA, Bero LA. Assessing faculty financial relationships with industry. JAMA 2000; 284:2209-2214.
36. Zuckerman JD, Prassarn M, Kubiak EN, Koval KJ. Conflict of interest in orthopaedic research. J Bone Joint Surg 2004; 86:423-428.
37. Gorawara-Bhat R, Gallagher TH, Levinson W. Patient-provider discussions about conflicts of interest in managed care: Physicians' perceptions. Am J Manag Care 2003; 9:564-671.
38. Kim SYH, Millard RW, Nisbet P, et al. Potential research participants' views regarding researcher and institutional financial conflicts of interest. J Med Ethics 2004; 30:73-79.
39. Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: Issues for clinical investigators. Acad Med 2003; 78:769-774.
40. Hussain A, Smith R. Declaring financial competing interests: Survey of five general medical journals. BMJ 2001; 323:263-264.
41. Roberts LW, Geppert CM, Connor R, et al. An invitation for medical educators to focus on ethical and policy issues in research and scholarly practice. Acad Med 2001; 73:876-885.
42. Gross CP, Gupta AR, Krumholz HM. Disclosure of financial competing interests in randomised controlled trials: Cross sectional review. BMJ 2003; 326:526-527.
43. Hartmann M, Knoth H, Schulz D, Knoth S. Industry-sponsored economic studies in oncology vs. studies sponsored by nonprofit organizations. Br J Cancer 2003; 89:1405-1408.
44. Friedberg M, Beranard S, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 1999; 282:1453-1457.
45. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet 2000; 356:635-638.
46. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer-supported trials of the nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994; 154:157-163.
47. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium channel antagonists. N Engl J Med 1998; 338:101-106.
48. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998; 279:1566-1570.
49. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170:477-480.
50. Rochon PA, Gurwitz JH, Cheung M, et al. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994; 272:108-113.
51. Choudry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287:612-617.
52. Cialdini RB, Trost MR. Social Influence: social norms, conformity, and compliance. In: Gilbert DT, Fiske ST, Lindzey G, editors. The handbook of social psychology. 4th ed. New York: McGraw-Hill; 1998. pp. 151-192.
53. Wegner DM, Bargh JA. Control and automaticity in social life. In: Gilbert DT, Fiske ST, Lindzey G, editors. The handbook of social psychology. 4th ed. New York: McGraw-Hill; 1998. pp. 446-496.
54. McCrary VS, Anderson CB, Jakovljevic J, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 2000; 343:1621-1626.
55. Lo B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. N Engl J Med 2001; 343:1616-1620.
56. Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest of US universities. JAMA 2000; 284:2203-2208.